U.S. Markets open in 6 hrs 40 mins

See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.

IHS Markit

Alexion Pharmaceuticals Inc

NASDAQ/NGS:ALXN

Score: Positive (79)

57 days at current score.

Upgraded from Neutral on April 13th 2018

Summary


  • This company ranked positively compared to the Healthcare sector despite only 1 positive IHS Markit Category
  • ETFs holding this stock have seen outflows over the last one-month
  • Bearish sentiment is low


Bearish sentiment

Short interest | Positive

Short interest is extremely low for ALXN with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ALXN.

Money flow

ETF/Index ownership | Negative

There is no ETF activity data available for this security.

Economic sentiment

PMI by IHS Markit | Neutral

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is very weak relative to the trend shown over the past year. In fact, it has been weak enough that the rate of expansion may accelerate in the coming months.

Credit worthiness

Credit default swap

CDS data is not available for this security.

View full report here!

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.